Scinai Immunotherapeutics Stock (NASDAQ: SCNI) stock price, news, charts, stock research, profile.
Open | $2.85 |
Close | $2.98 |
Volume / Avg. | 32.87K / 535.00K |
Day Range | 2.85 - 3.09 |
52 Wk Range | 2.23 - 13.70 |
Market Cap | $1.73M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 9.07% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Scinai Immunotherapeutics (NASDAQ:SCNI) through any online brokerage.
Other companies in Scinai Immunotherapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Exicure (NASDAQ:XCUR), Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR) and Entero Therapeutics (NASDAQ:ENTO).
There is no analysis for Scinai Immunotherapeutics.
There is no analysis for Scinai Immunotherapeutics to provide a consensus price target.
The stock price for Scinai Immunotherapeutics (NASDAQ: SCNI) is $2.98 last updated July 2, 2024 at 7:02 PM EDT.
There are no upcoming dividends for Scinai Immunotherapeutics.
Scinai Immunotherapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Scinai Immunotherapeutics.
Scinai Immunotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.